Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Baricitinib was effective in treating alopecia areata in two major trials.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Baricitinib works better than methotrexate for severe alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

The treatment was not recommended due to limited effectiveness and significant side effects.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Immunoadsorption successfully treated a man's resistant polymyositis.

Finasteride increases CD8+ T cells in BPH tissues.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Some gonadal hormone drugs can block filovirus entry into cells.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Both steroids, especially cyproterone acetate, harm quail's vital organs.